Lotiglipron
Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus
Pfizer · Phase 1 · Completed · Enrollment 34
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.